Abstract
The ovarian hyperstimulation syndrome (OHSS) is the most serious complication of ovarian stimulation. It has been estimated that the incidence of severe OHSS in patients undergoing ovarian stimulation for IVF is about 2% (1). Only supportive rather than curative therapy is available, and there are no clinical characteristics that are completely reliable in predicting OHSS. In addition, none of the strategies aimed at prevention are ideal; at best, they may slightly reduce the incidence of OHSS, but at a high emotional and financial cost.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
